Clinical Trials Directory

Trials / Terminated

TerminatedNCT01860092

New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System

Status
Terminated
Phase
Study type
Observational
Enrollment
53 (actual)
Sponsor
Second Sight Medical Products · Industry
Sex
All
Age
25 Years
Healthy volunteers
Not accepted

Summary

This post-approval study is being implemented to monitor the use of Argus II System in a larger US population than available within pre-approval studies. An attempt will be made to include all eligible and willing subjects implanted with Argus II System in the United States.

Detailed description

Safety data will be monitored to ensure continued acceptability of risks to study subjects. The utility (i.e. visual function and functional vision) and reliability of Argus II System will also be evaluated. There is no study hypothesis.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2020-03-01
Completion
2020-03-01
First posted
2013-05-22
Last updated
2021-12-23

Locations

17 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01860092. Inclusion in this directory is not an endorsement.